Huda Zoghbi sold $7.2M of Regeneron Pharmaceuticals stock
By AlphaYouPublished Form 4
Zoghbi Huda Y
Reporting filer
Huda Zoghbi reported selling 7,439 shares of Regeneron Pharmaceuticals, Inc. for about $7.2M ($970.46 a share on average). Form 4 filed Nov 5, 2026 lists 4 entries.
See the price move since this trade →
- Disclosed
- Nov 5, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Zoghbi Huda Y | 2026-11-03 | M | Exercise or conversion | 7439 | 380.95 | 9,142 | 2 days | Filed terms
|
| Common Stock | Zoghbi Huda Y | 2026-11-03 | S | Sale | 6939 | 970.42 | 2,203 | 2 days | Filed terms
|
| Common Stock | Zoghbi Huda Y | 2026-11-03 | S | Sale | 500 | 971.06 | 1,703 | 2 days | Filed terms
|
| Non-Qualified Stock Option (right to buy) (derivative) | Zoghbi Huda Y | 2026-11-03 | M | Exercise or conversion | 7439 | 0.0 | 0 | 2 days | Filed terms
|
Common Stock
- Owner
- Zoghbi Huda Y
- Date
- 2026-11-03
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 7439
- Price
- 380.95
- Following holdings
- 9,142
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 7439
- transaction Price Per Share: 380.95
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 9142
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Zoghbi Huda Y
- Date
- 2026-11-03
- Code
- S
- Action
- Sale
- Quantity
- 6939
- Price
- 970.42
- Following holdings
- 2,203
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 6939
- transaction Price Per Share: 970.42
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 2203
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Zoghbi Huda Y
- Date
- 2026-11-03
- Code
- S
- Action
- Sale
- Quantity
- 500
- Price
- 971.06
- Following holdings
- 1,703
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 500
- transaction Price Per Share: 971.06
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 1703
- direct Or Indirect Ownership: D
Non-Qualified Stock Option (right to buy) (derivative)
- Owner
- Zoghbi Huda Y
- Date
- 2026-11-03
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 7439
- Price
- 0.0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Non-Qualified Stock Option (right to buy)
- conversion Or Exercise Price: 380.95
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 7439
- transaction Price Per Share: 0.0
- transaction Acquired Disposed Code: D
- id: F3
- expiration Date: 2028-01-02
- underlying Security Title: Common Stock
- underlying Security Shares: 7439
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Zoghbi Huda Y: Director.
- F1: Represents volume-weighted average price of sales of 6,939 shares of Company stock on November 3, 2026 at prices ranging from $970.00 to $970.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 3, 2026 at each separate price.
- F2: Represents volume-weighted average price of sales of 500 shares of Company stock on November 3, 2026 at prices ranging from $971.00 to $971.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 3, 2026 at each separate price.
- F3: The stock option vested in three equal annual installments, commencing one year after the date of grant.
Original sources
Prepared automatically from public filing data. Report a correction.